Cambridge Healthtech Institute’s Fourth Annual 

Managing Late Stage Research, Observational Studies and Registries: 

Overcoming Operational Challenges
February 24-25, 2015 | Hyatt Regency Orlando | Orlando, FL 


Non-interventional studies are an integral part of clinical development programs and product development plans. Product benefit risk profile, comparative effectiveness data, and health economic evidences obtained from non-interventional studies are essential for multiple stakeholders, including regulatory agencies, payers, health care management organizations, formulary inclusion decision makers, healthcare professionals, as well as patients. Cambridge Healthtech Institute’s Fourth Annual Managing Late Stage Research, Observational Studies and Registries conference is designed to facilitate knowledge exchange around all aspects of observational research, from design of non-interventional studies and their management to application of the obtained data to business and stakeholder decisions.

 

Designing Observational Studies  

Streamlining Real World Data Flow and Analysis  

Indiana Strombom, Ph.D., Business Lead, Roche Pharma Real World Data/Evidence (Tentative)

Observational Data Collection Studies: Considerations to Minimize Bias 

Alicia Gilsenan, Ph.D., Senior Director, Epidemiology, RTI Health Solutions 

Supplemental Data Collection to Confirm Medical Events (ME) in Post-Marketing Pharmacoepidemiology Database Studies 

Fei Xue, M.D., Observational Research Director, Center for Observational Research (CfOR), Amgen, Inc.

 

Managing Observational Studies AND REGISTRIES 

Next Generation Oncology Registry Management, Big Data Considerations and Applications 

Jomol Mathew, Ph.D., Director, Clinical and Translational Informatics, IS, Dana-Farber Cancer Institute


Increasing Late Stage Patient Recruitment through Patient-Centered Technologies
 

Nariman Nasser, Digital Strategist, Genentech 

 

Applying Generated Data to Business and Stakeholder Decisions  

Using Observational Research and Registries to Support Drug Development across the Lifecycle: Pfizer’s Experience 

Rachel Sobel, Dr.PH., Senior Director, Epidemiology - Team Lead Global Innovative Pharmaceuticals, Pfizer, Inc. 


2015 Summit for Clinical Ops Executives (SCOPE) Conference at a Glance Large 

SCOPE 2014 Wrap-Up
Held February 4-6, 2014, in Miami, Florida, the 5th Annual SCOPE Summit gathered more than 700 industry leaders, an attendance increase of 18% from 2013, for three stimulating days of in-depth discussions covering important issues in clinical trial planning and management. With 11 different conference tracks, a Clinical Informatics News Best Practices Awards and two plenary keynote sessions, SCOPE offered advances and innovative solutions in all aspects of clinical trial management and operations, including Data Integration, Feasibility, Site Selection and Management, Recruitment and Retention, Social Media and Mobile Tech, Project Management, Forecasting, Aggregate Spend Compliance, Post-Marketing Studies, and Sample Logistics. The impressive executive audience at SCOPE came together for invaluable networking opportunities with more than 70% of the attendees titled as Executives from leading Pharma (16%), CRO (32%), and Biotech companies (26%). Industry leaders and key decision makers representing 16 different countries and more than 350 unique organizations shared case studies, collaborated on best practices and provided unique perspectives on poignant issues that the field currently faces.

For questions or suggestions about the meeting, please contact:
Marina Filshtinsky, M.D.
Conference Producer
Cambridge Healthtech Institute (CHI)
T: (+1) 781.972.5496
E: mfilshtinsky@healthtech.com 

For partnering and sponsorship information, please contact:
Ilana Quigley
Manager, Business Development
Cambridge Healthtech Institute (CHI)
T: (+1) 781.972.5457
E: iquigley@healthtech.com 

For media and association partnerships, please contact:
Rich Handy
Senior Director, Marketing
Cambridge Healthtech Institute (CHI)
T: (+1) 781.972.5456
E: rhandy@healthtech.com 

About Cambridge Healthtech Institute (CHI)
Founded in 1992, Cambridge Healthtech Institute (CHI) (www.chicorporate.com) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. Delivering an assortment of resources such as events, reports, publications and eNewsletters, CHI's portfolio of products include Cambridge Healthtech Institute Events, Pharmaceutical Strategy Series, Barnett International, Insight Pharma Reports, Marketing Services, and Cambridge Healthtech Media Group.


 

Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag  


> Event-At-A-Glance
Event-At-A-Glance 

> Download 2014 Brochure
  2014 SCOPE Brochure Image 

> Premier Sponsors 

 BBK 

 ClinicalInk 

Drug Dev 

IMS Health 

 Mapi 

QUINTILES
 

> View All Sponsors 

> View Media Partners 

> Attendee Profile